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Abstract
Background/aim: The aims of this study were to primarily investigate fatigue and sleep and to secondarily examine possible relationships
between disease activity, pain, and functional ability in children and adolescents with juvenile idiopathic arthritis (JIA).
Materials and methods: Ninety-six patients were enrolled in the study. Disease activity, functional ability, fatigue symptoms, fatigue
severity, and sleep quality were assessed with the Juvenile Arthritis Disease Activity Score (JADAS), Childhood Health Assessment
Questionnaire (CHAQ), Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale (PedsQL-F), visual analog scale (VAS), and
Pittsburgh Sleep Quality Index (PSQI), respectively.
Results: Fatigue severity was moderate to high in 75% of patients with JIA and sleep quality was poor in 40% of them. VAS-fatigue
was correlated with VAS-pain, VAS-wellbeing, PSQI, and sleep duration (P < 0.001). Significant relationships were found between the
PedsQL-F and all other parameters except JADAS (P < 0.05). VAS-fatigue, CHAQ, and PSQI were identified as significant predictors of
PedsQL-F (P < 0.05). Sleep quality, pain, and sleep duration were also significant predictors of fatigue severity (P < 0.05).
Conclusion: This study suggests that fatigue and sleep problems are common problems in JIA. If underlying factors of fatigue and sleep
are understood, strategies for improving sleep/fatigue paradox may develop in JIA.
Key words: Juvenile idiopathic arthritis, fatigue, sleep, pain, function

1. Introduction
Juvenile idiopathic arthritis (JIA) is a broad term that
describes a clinically heterogeneous group of arthritis of
unknown cause, which begins before 16 years of age (1).
Children with JIA become fatigued easily; experience joint
inflammation, pain, and limited mobility; and report poor
sleep quality and daytime sleepiness (2–6). It is reported in
the literature that children with JIA suffer from poor sleep,
parasomnias, daytime sleepiness, sleep fragmentation,
cyclic alternating pattern increase, and sleep-disordered
breathing compared to healthy children (2,4). Sleep was
disturbed in almost half of the patients with both JIA
and juvenile dermatomyositis, and sleep disturbance and
fatigue were both correlated with disease activity. Increased
pain is associated with more sleep disturbance and more
fatigue, and these appear to negatively influence quality of
life (3). The cause of sleep disturbance in patients with JIA

has yet to be elucidated. Zamir et al. (2) highlighted that
the sleep abnormality in JIA patients was associated with
pain, while Ward et al. (7) remarked that sleep duration
was associated with symptoms of fatigue. Bloom et al.
suggested a bidirectional interplay between pain and sleep
disturbance (4).
A study reported increased fatigue in children with
polyarticular JIA, irrespective of whether they had active
or inactive disease, compared to healthy controls (8).
Other studies clarified statistically significant correlations
between parent-reported fatigue and parent/childreported disease activity, including parent/child-reported
tender and swollen joint counts, and physician assessment
of disease activity (3,9).
In another study, it was reported that functional ability
was most strongly associated with parent- and childreported fatigue and pain was underlined as an important
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confounder between disease activity and fatigue (10).
Similarly, another study demonstrated a significant
association between fatigue and functional ability in adult
patients with rheumatoid arthritis (11). In another study,
it was remarked that children and adolescents with JIA
suffer from chronic or recurrent pain and disability, which
can severely limit their ability to complete daily physical
tasks and participate in school and social activities (12).
However, relations among sleep quality, pain, fatigue,
and functional ability in children with JIA have been not
been well studied. The aims of this study were to primarily
investigate fatigue and sleep and to secondarily examine
possible relationships between disease activity, pain, and
functional ability in children and adolescents with JIA.
2. Materials and methods
2.1. Patients
All patients attending the outpatient clinic of the
Department of Pediatric Rheumatology were recruited
between February 2015 and December 2015 to participate
in this study. All participants signed informed consent
forms. The participants were volunteers who were examined
by the pediatric rheumatologist who participated in the
present study. Approval for this study was obtained from
the Research Ethics Committee of İstanbul University
(No: A29/03.Feb.2015) and the study was conducted in
accordance with the Declaration of Helsinki.
Inclusion criteria consisted of a diagnosis of JIA
according to the International League of Associations for
Rheumatology criteria (13), being aged between 6 and
18 years, and being able to read and write in Turkish. All
patients were diagnosed with JIA 6 months prior to the
study. Patients were excluded from the study if they had
a second rheumatic or other chronic disease, a history of
mental deficit or psychological problems, or no approval
from their families to participate in the study. When all
patients attending our clinic during the study duration
were assessed, 96 of them fulfilled the inclusion criteria and
had approval from their families to participate. Thus, the
sample size was 96 patients. These patients’ characteristics
(sex and age) and disease characteristics (disease duration
and disease activity) were collected by the physiotherapists.
2.2. Evaluation of disease activity
A blood sample was taken for erythrocyte sedimentation
rate (ESR) and disease activity was assessed by the pediatric
rheumatologist using the Juvenile Arthritis Disease
Activity Score (JADAS). JADAS is a new composite disease
activity score speciﬁc to JIA. It is simple to calculate using
four variables measured in the clinical setting: active joint
count, physician global, parents global, and ESR. JADAS
has three practicable versions, which differ in the active
joints count incorporated: JADAS10, JADAS27, and
JADAS71. JADAS27 includes the following joints: cervical

spine, elbows, wrists, metacarpophalangeal joints (from
first to third), proximal interphalangeal joints, hips, knees,
and ankles. In this study, JADAS27 was preferred for its
better performance in validation analyses (14). JADAS27
was calculated as the simple sum of the scores of its four
components, which yields a global score of 0–57 (27 joints
+ physician global with 10-cm visual analog scale (VAS)
+ parent global with 10-cm VAS + ESR). The ESR value
is normalized to a 0–10 scale according to the following
formula: (ESR (mm/hour) – 20)/10. Before making the
calculation, ESR values of <20 mm/h were converted to 20
and ESR values of >120 m/h were converted to 120 (15).
The JADAS27 cutoff score for low disease activity was ≤2.7
and for high disease activity was ≥6 (16).
2.3. Evaluation of functional ability
Functional ability was assessed using the Turkish version
of the Childhood Health Assessment Questionnaire
(CHAQ). CHAQ is a reliable and valid tool for the
assessment of functional ability in patients with JIA (17).
In 8 activities (dressing/grooming, arising, eating, walking,
hygiene, reach, grip, and activities), a number of questions
were answered and scored on a scale of 0–3, where 0 = able
to do with no difficulty, 1 = able to do with some difficulty,
2 = able to do with much difficulty, and 3 = unable to do.
The mean of the 8 scores identified the CHAQ score (range:
0–3). CHAQ also provided an assessment of discomfort
using a 100-mm VAS for the evaluation of pain and a
100-mm VAS for the evaluation of overall wellbeing. A
score of 0 indicated “no pain” and 100 indicated “extreme
pain” for VAS pain, and a score of 0 indicated “very well”
and 100 “very bad” for VAS overall wellbeing. A higher
score indicated more problems in both pain and overall
wellbeing (18).
2.4. Evaluation of fatigue
Fatigue was evaluated in detail as fatigue symptoms and
fatigue severity. Fatigue symptoms were evaluated with
Pediatric Quality of Life Inventory-Multidimensional
Fatigue Scale (PedsQL-F). PedsQL-F is a valid and reliable
tool, and it can be used to measure symptom-specific
fatigue among patients with JIA (19). PedsQL-F, which
is an 18-item questionnaire designed to measure the
child’s and the parent’s perception of fatigue in pediatric
patients, comprises a general fatigue scale (6 items), sleep/
rest fatigue scale (6 items), and cognitive fatigue scale
(6 items). Fatigue severity was assessed with a 100-mm
VAS. A VAS score of <20 mm indicated “low fatigue”, VAS
score between 20 and 49 mm indicated “clinically relevant
fatigue”, and VAS score of ≥50 mm indicated “high fatigue”
(20).
2.5. Evaluation of sleep
Sleep quality was evaluated with the Pittsburgh Sleep
Quality Index (PSQI). The PSQI is a 23-item questionnaire
that generates scales reflecting daytime dysfunction, sleep
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latency, disturbance, duration, quality, and efficiency. As
the score increases, sleep quality decreases and daytime
dysfunction due to sleep quality disorder increases. The
PSQI is composed of three main scores: total PSQI score,
PSQI subscores, and sleep quality status score. PSQI
subscores are subjective sleep quality, time needed to fall
into sleep, sleep efficiency, use of medication, and daytime
sleepiness. Each component is scored from 0 to 3, leading
to a global PSQI score between 0 and 21, with higher scores
indicating lower quality of sleep (21). The PSQI is useful
to identify good and poor sleepers. A global PSQI score
above 5 indicates poor sleep (22). Patients were also asked
about times of falling asleep and getting up. Sleep time was
calculated by asking the patients about their sleeping and
awakening hours.
2.6. Statistical analysis
Data were evaluated using SPSS 21.0 for Windows (IBM
Corp., Armonk, NY, USA) and by analyzing descriptive
statistics (frequency, mean, and standard deviation).
Before the statistical analysis, the Kolmogorov–Smirnov
test was used to test for normal distribution of data.
The independent sample t-test was used to determine
differences of subjects’ outcome scores because the data
were normally distributed. Intercorrelations between

parameters were computed with Pearson’s correlation
analysis. Variables that were significantly associated
with PedsQL-F-patient and VAS-fatigue by Pearson’s
correlation analysis were included in the multivariable
model. Stepwise selection using a significance level of
P < 0.05 was employed to obtain the final multivariable
models. P < 0.05 was considered statistically significant for
all tests. Bonferroni’s correction was applied (P < 0.05/n,
where n = number of groups) when multiple comparisons
were made and P < 0.017 was considered statistically
significant for fatigue severity groups.
3. Results
3.1. Patients characteristics
A total of 96 eligible patients with JIA (61 female, 35 male)
were enrolled including 42 (43.8%) with polyarticular
onset (poly-JIA), 33 (34.8%) with oligoarticular (oligoJIA) subtype, 14 (14.6%) with systemic onset (ss-JIA), and
7 (7.3%) with other subtypes. The clinical characteristics
and scores of all outcomes of the patients are presented in
Table 1.
3.2. Fatigue
According to the VAS-fatigue data, only 25% of the
patients (n = 24) reported having a low level of fatigue

Table 1. Demographic and clinical results of patients with juvenile idiopathic
arthritis.
Demographic and clinical results

Patients (n = 96)
Mean ± SD / Median (IQR)

Age (years)

12.93 ± 3.36

BMI (kg/m )

19.16 ± 3.89

Disease duration (years)

5.78 ± 3.75

JADAS

3.75 (5.13)

PedsQL-F

67.62 ± 22.40

VAS-fatigue

40 (30)

VAS-pain

17.50 (40)

VAS-wellbeing

30 (40)

CHAQ

0.37 (0.87)

PSQI

4 (3)

Sleep duration (h/day)

8.43 ± 1.59

2

n (%)
Disease activity (low/moderate/high)

44/32/20 (45.9%, 33.3%, 20.8%)

Sex (F/M)

61/35 (63.5%, 36.5%)

JIA: Juvenile idiopathic arthritis, BMI: body mass index, F: female, M: male,
JADAS: Juvenile Arthritis Disease Activity Score, VAS: visual analog scale,
PedsQL-F: Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale,
CHAQ: Childhood Health Assessment Questionnaire, PSQI: Pittsburgh Sleep
Quality Index.
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(<20 mm); the VAS-fatigue score was between 20 and 49
mm for 44.8% of the patients (n = 43) having clinically
relevant fatigue and ≥50 mm (high fatigue) for 30.2% (n =
29). Table 2 shows scores of JADAS, PedsQL-F, VAS-pain,
VAS-wellbeing, CHAQ, PSQI, and sleep duration in the
fatigue severity groups. There, ≥50 mm was statistically
significant different in the comparisons of the results of
JADAS, PedsQL-F, VAS-pain, VAS-wellbeing, PSQI, and
sleep duration in the fatigue severity groups. In particular,
the differences between patients with low levels of fatigue
and high levels of fatigue were statistically significant (P <
0.017).
When the JIA subtypes were compared due to scores
for PedsQL-F (poly-JIA = 67.92 ± 21.02, oligo-JIA = 67.63
± 23.54, ss-JIA = 64.58 ± 28.26, other = 71.82 ± 13.90) and
VAS-fatigue (poly-JIA = 3.64 ± 1.93, oligo-JIA = 3.59 ±
2.82, ss-JIA = 2.69 ± 2.21, other = 4.28 ± 1.88), there was
no statistically significant difference in the comparisons of
the results of PedsQL-F (P = 0.919) or VAS-fatigue (P =
0.473) in the JIA subtype groups.
3.3. Sleep
The mean of sleep duration was 8.43 ± 1.59 h, while 66
(68.8%) patients reported that they slept less than 10
h. Fifty-eight (60.4%) patients had PSQI scores of <5,
indicating good sleep quality, while 38 (39.6%) patients
had PSQI scores of >5, indicating poor sleep quality. When
the JIA subtypes were compared according to PSQI scores
(poly-JIA = 4.74 ± 2.26, oligo-JIA = 3.79 ± 2.58, ss-JIA =
3.5 ± 2.24, other = 5 ± 1.91) and sleep duration (poly-JIA
= 8.25 ± 1.52, oligo-JIA = 8.79 ± 1.67, ss-JIA = 8.42 ± 1.28,
other = 7.85 ± 2.11), there was no statistically significant
difference in the comparisons of the results of the PSQI (P
= 0.166) or sleep duration (P = 0.377) in the JIA subtype

groups. PSQI scores were not different due to JIA subtype.
Table 3 shows the comparisons of the results of sleep
duration, JADAS, PedsQL-F, VAS-fatigue, CHAQ, VASpain, and VAS-wellbeing in patients with good/poor sleep
quality. Almost all parameters of patients with poor sleep
were statistically significantly worse than in patients with
good sleep (P < 0.05).
3.4. Relationships between disease activity, fatigue, functional ability, pain, wellbeing, sleep quality, and sleep
duration
Table 4 shows the correlations of the results of JADAS,
PedsQL-F, CHAQ, VAS-fatigue, VAS-pain, VAS-wellbeing,
PSQI, and sleep duration. Significant relationships were
found between JADAS and VAS-fatigue (r = 0.303), VASpain (r = –0.329), and VAS-wellbeing (r = –0.330) (P <
0.05). Significant relationships were also found between
PedsQL-F and all other parameters except JADAS (P <
0.05). VAS-fatigue was significantly correlated with VASpain (r = 0.544), VAS-wellbeing (r = 0.539), PSQI (r =
0.496), and sleep duration (r = –0.229) (P < 0.001). On
the other hand, it was found that CHAQ was significantly
correlated with PedsQL-F (r = –0.501), VAS pain (r =
0.298), and VAS-overall wellbeing (r = 0.331); VAS-pain
was significantly correlated with VAS-overall wellbeing
(r = 0.583) and PSQI (r = 0.328); and VAS-wellbeing was
significantly correlated with PSQI (r = 0.471) (P < 0.001).
In addition, sleep duration was significantly correlated
with PSQI (r = –0.272) (P < 0.01). It was also found that
age (r = –0.091, P = 0.378), sex (r = 0.024, P = 0.815),
disease duration (r = 0.003, P = 0.981), and disease type
(r = 0.008, P = 0.936) were not statistically correlated with
PedsQL-F. Similarly, it was found that age (r = –0.106, P
= 0.303), sex (r = –0.17, P = 0.314), disease duration (r =

Table 2. Disease activity, fatigue symptoms, pain severity, wellbeing, functional ability, sleep quality, and sleep duration in the fatigue
severity groups.
VAS-F < 20 mm VAS-F of 20–49 mm
(1) n = 24
(2) n = 43
Median (IQR)
Median (IQR)

VAS-F ≥ 50 mm
(3) n = 29
Median (IQR)

P
(1) - (2) - (3) (1) - (2) (1) - (3)

(2) - (3)

JADAS

1.60 (2)

3 (5.10)

4 (3.90)

0.041

0.286

0.025

0.329

PedsQL-F

91.66 (20.83)

73.61 (20.83)

58.33 (23.25)

0.003

0.550

0.004

0.022

VAS-pain

0 (5)

20 (40)

40 (47.75)

0.0001

0.209

0.000

0.007

VAS-wellbeing

10 (25)

30 (30)

50 (23.8)

0.001

0.019

0.001

0.321

CHAQ

0.25 (0.75)

0.25 (0.37)

0.56 (1)

0.535

0.582

0.983

0.669

PSQI

2 (2)

4 (2)

5 (4)

0.002

0.262

0.001

0.039

Sleep Duration (h/day)

9 (2)

8 (3)

8 (2)

0.010

0.356

0.008

0.100

VAS-F: Visual analog scale-fatigue. (1): VAS-F < 20 mm. (2): VAS-F of 20–49 mm. (3): VAS-F ≥ 50 mm. JADAS: Juvenile Arthritis
Disease Activity Score. PedsQL-F: Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale. CHAQ: Childhood Health
Assessment Questionnaire. PSQI: Pittsburgh Sleep Quality Index. Bonferroni’s correction, P < 0.01.
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Table 3. Comparisons of the results of disease activity, fatigue symptoms, fatigue severity, pain severity,
wellbeing, functional ability, and sleep duration in patients in good/poor sleep quality groups.
Good sleep
n = 58 (60.4%)

Poor sleep
n = 38 (39.6%)

Mean ± SD

Mean ± SD

t

p

Sleep duration (h)

8.72 ± 1.52

7.98 ± 1.61

2.242

0.028

JADAS

4.65 ± 4.31

6.96 ± 4.96

–2.418

0.018

PedsQL-F

75.45 ± 19.19

55.66 ± 21.86

4.674

0.000

VAS-fatigue

28.4 ± 22.8

49.7 ± 19.9

–4.508

0.000

VAS-pain

16.81 ± 22.25

34.47 ± 25.00

–3.620

0.000

VAS-wellbeing

27.06 ± 24.13

53.15 ± 22.94

–5.281

0.000

CHAQ

0.49 ± 0.53

0.68 ± 0.70

–1.528

0.130

JADAS: Juvenile Arthritis Disease Activity Score. VAS: Visual analog scale. PedsQL-F: Pediatric Quality of
Life Inventory-Multidimensional Fatigue Scale. CHAQ: Childhood Health Assessment Questionnaire.

Table 4. Correlations of the results of disease activity, fatigue symptoms, fatigue severity, pain severity, wellbeing, functional ability, sleep
quality, and sleep duration in patients with juvenile idiopathic arthritis
JADAS

PedsQL-F

VAS-fatigue

CHAQ

VAS-pain

VAS-global
wellbeing

PedsQL-F

r = 0.030
P = 0.771

VAS-fatigue

r = 0.303
P = 0.003

r = –0.484
P = 0.0001

CHAQ

r = 0.179
P = 0.586

r = –0.501
P = 0.0001

r = 0.124
P = 0.402

VAS-pain

r = –0.329
P = 0.011

r = –0.329
P = 0.001

r = 0.544
P = 0.0001

r = 0.298
P = 0.023

VAS-wellbeing

r = 0.330
P = 0.001

r = –0.357
P = 0.001

r = 0.539
P = 0.0001

r = 0.331
P = 0.002

r = 0.583
P = 0.0001

PSQI

r = 0.182
P = 0.076

r = –0.492
P = 0.0001

r = 0.496
P = 0.0001

r = 0.184
P = 0.380

r = 0.328
P = 0.001

r = 0.471
P = 0.001

Sleep duration

r = 0.087
P = 0.411

r = 0.242
P = 0.018

r = –0.229
P = 0.001

r = 0.032
P = 0.986

r = –0.129
P = 0.133

r = –0.143
P = 0.141

PSQI

r = –0.272
P = 0.008

JADAS: Juvenile Arthritis Disease Activity Score. VAS: Visual analog scale. PedsQL-F: Pediatric Quality of Life InventoryMultidimensional Fatigue Scale. CHAQ: Childhood Health Assessment Questionnaire. PSQI: Pittsburgh Sleep Quality Index.

0.140, P = 0.185), and disease type (r = –0.012, P = 0.908)
were not statistically correlated with VAS-fatigue.
3.5. Predictors of fatigue
In multivariate linear regression analysis, VAS-fatigue,
CHAQ, and PSQI were identified as statistically significant
predictors of PedsQL-F (P < 0.05). Moreover, sleep quality,
pain, and sleep duration were statistically significant
factors of fatigue severity (P < 0.05) (Table 5). In addition,
the clinical features of age, sex, disease duration, and

62

disease type were not significant predictors of PedsQL-F
or VAS-fatigue (P > 0.05).
4. Discussion
We found that fatigue affects 75% of patients with JIA, thus
making fatigue a common problem among this patient
population. We also found that 40% of them have poor
sleep quality and 69% of the patients slept less than 10 h.
When considering the percentile curves of sleep duration
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Table 5. Multivariate linear regression analysis of fatigue symptoms and fatigue severity in patients with juvenile idiopathic arthritis.
Predictor variable

PedsQL-F
B

Std.
error

%95 CI

Intercept

86.92

11.13

64.78 to 109.06

PSQI

–2.15

0.87

–3.91 to –0.35

VAS-fatigue
P

B

Std.
error

Beta

t
7.80

0.0001 3.45

1.15

1.16 to 5.74

–0.23

–2.38

0.019

0.08

0.13 to 0.48

0.32

95% CI

Beta

t

P

2.99

0.004

0.30

3.52

0.001

VAS-pain

0.05

0.09

–0.13 to 0.24

0.06

0.62

0.535

0.03

0.01

0.008 to 0.04

0.28

2.87

0.005

VAS-global wellbeing

0.05

0.08

–0.10 to 0.24

0.08

0.82

0.411

0.01

0.009

–0.005 to 0.03

0.14

1.45

0.150

Sleep duration

0.68

1.13

–1.25 to 3.28

0.07

0.88

0.378

–0.28

0.11

–0.55 to –0.08

–0.21

–2.71

0.008

CHAQ

–16.39

2.99

–22.02 to –9.92

–0.45

–5.25

0.000

–0.31

0.32

–0.49 to 1.16

0.08

0.80

0.422

JADAS

1.05

0.47

–0.93 to 1.34

0.03

0.35

0.722

0.08

0.05

–0.01 to 0.18

0.13

1.62

0.108

VAS-fatigue

–3.93

1.01

–5.39 to –1.34

–0.37

–3.30

0.001

Std: Standard. CI: Confidence interval. JADAS: Juvenile Arthritis Disease Activity Score. VAS: Visual analog scale. PedsQL-F: Pediatric
Quality of Life Inventory-Multidimensional Fatigue Scale. CHAQ: Childhood Health Assessment Questionnaire. PSQI: Pittsburgh
Sleep Quality Index.

presented by Iglowstein et al. (23), sleep durations of the
patients were less than those of healthy children. In line
with other studies (7,24–26), we found that fatigue and
sleep problems were also common problems in patients
with JIA. According to the results of our study, sleep
quality, sleep duration, and pain were predictors for fatigue
severity. Furthermore, fatigue severity, sleep quality, and
functional ability were predictors for fatigue symptoms.
Another important result of our study was that disease
activity was not a predictor of fatigue severity, whereas a
significant correlation was found between disease activity
and fatigue severity.
Our study has an important strong aspect. Unlike most
studies of fatigue in patients with JIA, we also assessed
fatigue symptoms and fatigue severity. We measured
fatigue symptoms using a validated and disease-specific
questionnaire that is commonly used in studying patients
with JIA (19). Besides, we have used the most common
scale to measure fatigue severity because we considered
that fatigue symptoms and fatigue severity may be
associated with different factors.
Previous studies have shown diverging results regarding
the relationships among fatigue, pain, functional ability,
and disease activity (3,8,10,27,28). Actually, none of these
studies evaluated fatigue in JIA multidimensionally. Some
of them found that fatigue was associated with disease
activity (10,27,29), but some of them reported that fatigue
was not associated with disease activity (3,7). Our finding
is the same as the last finding that disease activity did not
have an independent effect on fatigue, although 45.8%
of our patients with JIA had low disease activity. This
difference in outcomes may be attributed to differences in
several factors, including patient age, the questionnaires

used, and the treatment setting. On the other hand, pain is
clinically the most common symptom in patients with JIA
(30,31). Our finding showed that pain was a fairly strong
predictor of fatigue severity, while pain was correlated
with fatigue symptoms and severity in patients with JIA.
Similarly, previous studies reported that a significant
positive correlation was found between fatigue and pain
in patients with JIA (3,7,8). As a consequence, pain
affects other problems in patients with JIA because of its
biopsychosocial dimension. Our results also suggested
that functional ability was the strongest predictor of
fatigue symptoms, although it was not correlated with
fatigue severity in patients with JIA. Similarly, Rignold
et al. (10) noticed that functional ability, as measured
by CHAQ, was most strongly associated with fatigue in
patients with JIA. Bromberg et al. (28) noticed that fatigue
was not a predictor for functional limitations despite high
levels of fatigue in patients with JIA. This contradiction in
results may be due to differences between measurement
methods of fatigue. Moreover, the relationship between
fatigue and functional ability has rarely been studied in the
literature. Eventually, our finding emphasized that fatigue
severity and symptoms were affected by different factors.
Pain, sleep duration, and sleep quality were predictors of
fatigue severity, while functional ability, sleep quality, and
fatigue severity were predictors of fatigue symptoms in
patients with JIA. Our results will contribute to clarifying
the underlying reason for this dilemma.
Sleep is a critical developmental need for children
and adolescents and, when disturbed, is associated with
impairments in daily activities (32). Few studies have
examined sleep in children with JIA. In one study, sleep
duration was associated with fatigue symptoms (7).
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Laplant et al. (33) similarly showed that fatigue symptoms
were related to insomnia. In our study, sleep duration was
the strongest predictor of fatigue severity. Additionally,
while sleep duration of patients with JIA was decreased,
fatigue severity was significantly increased. Patients with
high fatigue severity had significantly more pain severity
than patients with low fatigue. Several previous studies also
demonstrated an association between poor sleep quality
and chronic widespread pain (2,3,6,34). Similarly, we
found that sleep quality was associated with pain and also
with fatigue symptoms and severity. It appears reasonable
that increased pain may have caused poor sleep in our
subjects. It is difficult to ascertain whether disturbed
sleep causes increased pain and fatigue, or whether pain
and increased fatigue lead to poor sleep. We believe that
the relationship between pain, poor sleep, and fatigue is
like a paradox in patients with JIA. Similarly, Butbut et
al. (3) supposed that this relationship may be a vicious
cycle with a significant influence on quality of life. Lewin
and Dahl (35) verified that a bidirectional theory of sleep
disturbance and pain can be suggested: not only can pain
interfere with sleep, but insufficient sleep can also have
negative effects on pain management. This cyclic pattern
could produce increased attention to pain problems,
affective disruption, and high-risk behaviors, all of which
can intensify the pain experience and accordingly disturb
the sleep. Breaking this vicious cycle may be an appropriate

therapeutic target for improving quality of life in patients
with JIA. As in our results, patients with good sleep have a
higher wellbeing. Thus, sleep quality is important to break
this vicious cycle.
There were several limitations in this study. Previous
studies indicated that psychological and emotional states
affect fatigue and sleep in patients with JIA, but we did
not assess the psychological and emotional states of our
patients. Also, we did not compare our patients with
a healthy control population, as we observed that the
differences in sleep and fatigue between JIA patients and
healthy controls had been adequately demonstrated.
In conclusion, fatigue and sleep disturbance are
considerable problems in patients with JIA. If underlying
factors of fatigue and sleep are understood, strategies for
improving the sleep/fatigue paradox may be developed in
patients with JIA. Moreover, these strategies should entail
a holistic and biopsychosocial approach. Therefore, further
studies should focus on all factors that may affect fatigue
and sleep comprehensively and investigate the effects of
these factors on the treatment of patients with JIA.
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